Investing in success: vaccine development and manufacturing

Is there value in investing in vaccines, in particular those for emerging markets or developing countries? Tell us your opinion below. Sanat Chattopadhyay, Senior Vice President, Global Vaccines & Sterile Manufacturing, Merck Manufacturing Division, Merck & Co joined us at the World Vaccine Congress in Washington in 2012 to demonstrate how investment in vaccine development and manufacturing has led to …

Why when vaccine trials fail it is a sad day for global public health

It saddens me to read about failed clinical trials in vaccines for many reasons, but mostly because of the impact these failures might have on the wider global vaccine research and development. With the recent news about Sanofi Pasteur's not as effective phase II trial results for their Dengue Fever vaccine, it just made me think how this will affect …